Go Pro
→ First Look: Elon’s “Starphone” (From Stansberry Research) (Ad)tc pixel
LON:4BB

4basebio Interim Earnings Report

4basebio logo
GBX 550.25 -12.25 (-2.18%)
As of 08:06 AM Eastern
ProfileEarnings HistoryForecast

4basebio EPS Results

Actual EPS
-GBX 50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

4basebio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

4basebio Announcement Details

Quarter
Interim
Date
9/29/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

4basebio Earnings Headlines

Average price target for 4basebio cut by 12.50% to 1,428.00 GBX
 |  msn.comhttps://www.msn.com/en-us/money/top-stocks/average-price-target-for-4basebio-cut-by-12-50-to-1-428-00-gbx/ar-AA2do22X
4Basebio Stock Price History
September 30 at 1:22 AM  |  investing.comhttps://www.investing.com/equities/4basebio-uk-societas-historical-data
Trump's crypto bank just got approved
Here's a detail almost everyone missed about last October. When crypto stumbled in October 2025, Trump's crypto team was only half built. His SEC chairman was in place. But the man now running the CFTC, crypto's other main regulator, hadn't even been nominated yet. This October is the first where both seats are filled with Trump's own picks, working from the same playbook... And the market already seems to sense it. Bitcoin just posted one of its strongest summers in years, gaining in both August and September. ETF buyers just had their biggest week since last fall. That's the backdrop heading into crypto's favorite month.tc pixel
October 2 at 1:00 AM  |  Crypto 101 Media (Ad)
4basebio PLC - Half-year Report for the six months ended 30 June 2026
September 29 at 8:22 PM  |  marketscreener.comM
4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company's Phase I Cell Therapy Program
September 29 at 8:22 PM  |  marketscreener.comM
4basebio (LON:4BB) Issues Earnings Results
September 29 at 7:57 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31064091
See More 4basebio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 4basebio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 4basebio and other key companies, straight to your email.

About 4basebio

4basebio (LON:4BB) is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

View 4basebio Profile
Earnings Tools